致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Biotinylated Human CD20/MS4A1, Avi-His-tag
目录号 NBL-240477
别名 CD20/MS4A1; MS4A1;CD20;MS4A-1;B-lymphocyte surface antigen B1;Bp35;Leukocyte surface antigen Leu-16;Membrane-spanning 4-domains subfamily A member 11
外观 see COA
分子量 Ile141-Ser188
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 P11836-1
备注2
目录号 规格 价格 库存状态  
NBL-240477-100ug 100ug Inquire Inquire
NBL-240477-1mg 1mg Inquire Inquire
NBL-240477-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Biotinylated Human CD20/MS4A1, Avi-His-tag


Catalog#:

NBL-240477


Description:

NebuSelect™ Recombinant Biotinylated Human CD20/MS4A1, Avi-His-tag(Cat#NBL-240477) is expressed in E.coli with His tag and Avi tag at the C-Terminus.It contains Ile141-Ser188.


Species:

Human


Expression System:

E.coli


Molecular Weight: 

The protein has a predicted MW of 16.8 kDa same as Bis-Tris PAGE result.


Target Name:

CD20/MS4A1; MS4A1;CD20;MS4A-1;B-lymphocyte surface antigen B1;Bp35;Leukocyte surface antigen Leu-16;Membrane-spanning 4-domains subfamily A member 11


Target Information:

B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117) and progressively increasing in concentration until maturity.CD20 is the target of the monoclonal antibodies rituximab, ocrelizumab, obinutuzumab, ofatumumab, ibritumomab tiuxetan, tositumomab, and ublituximab, which are all active agents in the treatment of all B cell lymphomas, leukemias, and B cell-mediated autoimmune diseases.


Amino Acid Sequence: 

Ile141-Ser188


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品